HOOKIPA Pharma (HOOK) Institutional Ownership $0.92 +0.01 (+0.55%) As of 03:46 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for HOOKIPA Pharma (NASDAQ:HOOK)CurrentInstitutional OwnershipPercentage63.88%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$4.13MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$73.92M Get HOOK Insider Trade Alerts Want to know when executives and insiders are buying or selling HOOKIPA Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data HOOK Institutional Buying and Selling by Quarter HOOKIPA Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Squarepoint Ops LLC51,960$104K0.0%N/A0.431% 2/17/2025 Millennium Management LLC15,326$31K0.0%N/A0.127% 2/14/2025 Gilead Sciences Inc.1,875,945$3.77M0.2%N/A15.555% 11/16/2024 Geode Capital Management LLC72,679$313K0.0%-89.7%0.603% 11/15/2024 State Street Corp16,967$73K0.0%-90.0%0.141% 11/15/2024 Redmile Group LLC106,376$457K0.0%-90.0%0.882% 11/15/2024 Ikarian Capital LLC53,076$228K0.0%N/A0.440% 11/15/2024 Baker BROS. Advisors LP812,814$3.50M0.0%-90.0%6.740% 11/14/2024 Knoll Capital Management LLC551,738$2.37M1.2%-90.0%4.577% 11/13/2024 FMR LLC341,476$1.47M0.0%-90.0%2.831% Get the Latest News and Ratings for HOOK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for HOOKIPA Pharma and its competitors with MarketBeat's FREE daily newsletter. 11/5/2024 GSA Capital Partners LLP16,609$71K0.0%-86.1%0.138% 8/9/2024 Renaissance Technologies LLC302,246$179K0.0%+38.4%3.055% 8/6/2024 Acadian Asset Management LLC991,106$586K0.0%+12.3%10.011% 5/20/2024 Virtu Financial LLC43,021$31K0.0%N/A0.043% 5/10/2024 Acadian Asset Management LLC882,262$627K0.0%+85.8%0.892% 11/15/2023 Redmile Group LLC1,063,769$655K0.0%-67.7%1.267% 11/15/2023 Armistice Capital LLC3,712,000$2.29M0.0%-3.7%4.422% 8/22/2023CHI Advisors LLC788,740$694K0.2%N/A1.441% 8/11/2023 Artal Group S.A.5,666,410$4.99M0.2%+206.4%10.355% 8/7/2023 Acadian Asset Management LLC428,353$375K0.0%-37.2%0.783% 8/4/2023 Maven Securities LTD146,037$129K0.0%N/A0.267% 7/24/2023 Vontobel Holding Ltd.45,000$40K0.0%N/A0.082% 5/11/2023 Acadian Asset Management LLC682,349$500K0.0%+6.0%1.247% 5/1/2023 Virtu Financial LLC62,308$46K0.0%N/A0.114% 2/14/2023 Susquehanna International Group LLP45,014$36K0.0%+99.5%0.082% 2/14/2023 EcoR1 Capital LLC2,473,489$2.00M0.1%-50.5%4.521% 11/10/2022 Connor Clark & Lunn Investment Management Ltd.22,102$30K0.0%N/A0.040% 11/7/2022 Virtu Financial LLC43,507$58K0.0%+50.9%0.080% 5/16/2022 Deep Track Capital LP5,035,998$11.48M0.7%N/A9.209% 5/12/2022 Artal Group S.A.1,849,616$4.22M0.2%+208.5%3.382% 5/11/2022 GSA Capital Partners LLP77,878$178K0.0%+124.2%0.142% 5/9/2022 Banque Cantonale Vaudoise20,000$46K0.0%N/A0.037% 2/14/2022 Redmile Group LLC2,385,136$5.56M0.1%+29.3%9.125% 2/14/2022 GSA Capital Partners LLP34,734$81K0.0%N/A0.133% 2/10/2022 Acadian Asset Management LLC252,256$587K0.0%+210.5%0.965% 1/28/2022 Allspring Global Investments Holdings LLC39,715$92K0.0%N/A0.152% 12/14/2021 UBS Asset Management Americas Inc.320,400$1.89M0.0%-3.3%1.226% 11/16/2021 Two Sigma Advisers LP85,600$504K0.0%+631.6%0.328% 11/16/2021 Two Sigma Investments LP186,356$1.10M0.0%+495.0%0.715% 11/15/2021 HighVista Strategies LLC12,051$71K0.0%N/A0.046% GENIUS Act: Cancel Your Money? (Ad)A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.Get the free info kit with 3 strategies to sidestep digital dollar control.11/12/2021 Geode Capital Management LLC405,421$2.39M0.0%+6.8%1.555% 11/12/2021 Connor Clark & Lunn Investment Management Ltd.12,869$76K0.0%N/A0.049% 11/9/2021 Barclays PLC16,368$96K0.0%+573.9%0.063% 11/9/2021BlackRock Inc.1,053,514$6.20M0.0%+0.3%4.041% 11/8/2021 Los Angeles Capital Management LLC50,591$298K0.0%+35.2%0.194% 11/5/2021 Advisory Services Network LLC11,800$70K0.0%N/A0.045% 8/17/2021 Woodline Partners LP901,602$8.26M0.2%+32.5%3.468% 8/17/2021 Millennium Management LLC387,917$3.55M0.0%N/A1.492% 8/16/2021 UBS Asset Management Americas Inc.331,212$3.03M0.0%N/A1.274% 8/16/2021 Cubist Systematic Strategies LLC23,624$216K0.0%N/A0.091% 8/16/2021 Nantahala Capital Management LLC512,108$4.69M0.1%-43.1%1.970% 8/16/2021 Redmile Group LLC1,856,205$17.00M0.3%+0.7%7.141% 8/16/2021 California State Teachers Retirement System26,486$243K0.0%+22.1%0.102% 8/16/2021 Hhlr Advisors LTD.269,368$2.47M0.0%-63.4%1.036% 8/16/2021 Royal Bank of Canada35,858$329K0.0%+200.3%0.138% 8/16/2021 Charles Schwab Investment Management Inc.47,694$437K0.0%+26.4%0.183% 8/16/2021 State Street Corp326,012$2.99M0.0%+65.7%1.254% 8/16/2021Nuveen Asset Management LLC172,522$1.58M0.0%+146.7%0.664% 8/16/2021 Federated Hermes Inc.248,983$2.28M0.0%+704.1%0.958% 8/16/2021 Goldman Sachs Group Inc.34,526$316K0.0%-80.2%0.133% 8/13/2021 Northern Trust Corp218,134$2.00M0.0%+32.6%0.839% 8/13/2021 Geode Capital Management LLC379,702$3.48M0.0%+12.0%1.461% 8/13/2021 Vanguard Group Inc.901,149$8.26M0.0%+1.4%3.467% 8/13/2021 FMR LLC2,030,600$18.60M0.0%-20.5%7.812% 8/12/2021 Dimensional Fund Advisors LP60,445$554K0.0%+63.8%0.233% 8/12/2021 JPMorgan Chase & Co.7,406$68K0.0%-80.2%0.028% 8/11/2021 Bank of New York Mellon Corp58,607$537K0.0%+45.6%0.225% 8/11/2021BlackRock Inc.1,050,521$9.62M0.0%+41.2%4.041% 8/11/2021 Deutsche Bank AG121,258$1.11M0.0%+1,330.1%0.466% 8/10/2021 Birchview Capital LP20,000$183K0.1%N/A0.077% 8/10/2021 Citigroup Inc.16,047$147K0.0%+1,293.0%0.062% 8/6/2021 Mitsubishi UFJ Kokusai Asset Management Co. Ltd.15,659$143K0.0%N/A0.060% 8/5/2021 Rhumbline Advisers13,390$123K0.0%N/A0.052% 8/5/2021 Los Angeles Capital Management LLC37,431$343K0.0%N/A0.144% (Data available from 1/1/2016 forward) HOOK Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of HOOK shares? During the previous two years, 15 institutional investors and hedge funds held shares of HOOKIPA Pharma. The most heavily invested institutionals were Gilead Sciences Inc. ($3.77M), Baker BROS. Advisors LP ($3.50M), Knoll Capital Management LLC ($2.37M), Armistice Capital LLC ($2.29M), FMR LLC ($1.47M), Acadian Asset Management LLC ($586K), and Redmile Group LLC ($457K).Learn more on HOOKIPA Pharma's institutional investors. What percentage of HOOKIPA Pharma's stock is owned by institutional investors? 63.88% of HOOKIPA Pharma's stock is owned by institutional investors. Learn more on HOOK's institutional investor holdings. Which institutional investors have been buying HOOKIPA Pharma's stock? The following institutional investors have purchased HOOKIPA Pharma's stock in the last 24 months: Gilead Sciences Inc. ($1.88M), Acadian Asset Management LLC ($516.38K), Renaissance Technologies LLC ($83.80K), Ikarian Capital LLC ($53.08K), Squarepoint Ops LLC ($51.96K), Virtu Financial LLC ($43.02K), and Millennium Management LLC ($15.33K). How much institutional buying is happening at HOOKIPA Pharma? Institutional investors have bought a total of 1,996,307 shares in the last 24 months. This purchase volume represents approximately $4.13M in transactions. Which of HOOKIPA Pharma's major shareholders have been selling company stock? The following institutional investors have sold HOOKIPA Pharma stock in the last 24 months: Baker BROS. Advisors LP ($7.32M), Knoll Capital Management LLC ($4.97M), FMR LLC ($3.06M), Redmile Group LLC ($957.39K), Geode Capital Management LLC ($635.15K), State Street Corp ($152.72K), and GSA Capital Partners LLP ($103.03K). How much institutional selling is happening at HOOKIPA Pharma? Institutional investors have sold a total of 17,191,802 shares in the last 24 months. This volume of shares sold represents approximately $73.92M in transactions. Related Companies Eagle Pharmaceuticals Institutional Ownership Renovaro Institutional Ownership LAVA Therapeutics Institutional Ownership Medicus Pharma Institutional Ownership CalciMedica Institutional Ownership Mersana Therapeutics Institutional Ownership Exicure Institutional Ownership OnKure Therapeutics Institutional Ownership Reviva Pharmaceuticals Institutional Ownership Xilio Therapeutics Institutional Ownership This page (NASDAQ:HOOK) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HOOKIPA Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HOOKIPA Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
